- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 40.07M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 40.81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 41.85M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $26.12M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $5.61M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $5.27M |
| Capex | Q1 2026 · Mar 31, 2026 | $3.15M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.96M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $171.7M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $209.93M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $936.12M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $594.86M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $69.39M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $308.77M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $213.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $774.36M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $746.42M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $654.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $650.28M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.27B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $863.99M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.04B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.61B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.89 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.83 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.91 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.85 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $132.18M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $92.15M |
| Net Income | Q1 2026 · Mar 31, 2026 | $36.05M |
| Net Income | Q1 2026 · Mar 31, 2025 | $34.72M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $65.31M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $56.34M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $62.51M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $0 |
| Revenue | Q1 2026 · Mar 31, 2026 | $116.93M |
| Revenue | Q1 2026 · Mar 31, 2025 | $3.71M |